Catholic University of Leuven
VERSANT HIV drug resistance assay effective
Published in Health Risk Factor Week, January 12th, 2004
In a recent study, scientists "evaluated the performance of the VERSANT HIV-1 Resistance Assays (LiPA) in detecting drug resistance in therapy-naive HIV-infected patients diagnosed in Belgium in 2000."
"We compared the results with population sequencing and found concordance to be in line with previous studies in treatment-experienced patients (86.87% for reverse transcriptase (RT); 92.77% for protease (PRO))," reported I. Derdelinckx and coauthors at the Catholic University of Leuven.
"Discordance was mainly due to indeterminate reactions on LiPA (8.45% for RT;...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- AIDS Prevention
U.N. envoy says clerics can help prevent spread of AIDS in Pakistan - Centers for Disease Control & Prevention
Health departments should adopt new notification policies for gay men - Ethicon, Inc.
FDA issues alert on counterfeit polypropylene mesh used in surgery - European Synchrotron Radiation Facility
3-D synchrotron radiation micro computed tomography reveals bone status - Finance
LanVision reports 14% revenue increase in third quarter compared to last year - Finance
Mariner Health Care agrees to sell $175M of 8.25% senior subordinated notes - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
